Nifty

:

25377.55

Sensex

:

82948.23

-41.00 (-0.16%)
-131.43 (-0.16%)

Login

Nifty
Sensex

:
:

25377.55
82948.23

-41.00 (-0.16%)
-131.43 (-0.16%)

Unichem Laboratories Ltd.

Pharmaceuticals & Drugs - Global

Rating :

N/A

BSE: 506690 | NSE: UNICHEMLAB

Watchlist

NSE BSE

533.55

05-Jul-2024

Open
High
Low
Previous Close

534.80
538.00
529.60
532.65

Volume
Traded Value (lacs)
52 Week High
52 Week Low

12096
64.57
694.70
396.10

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,604.54
N/A
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,669.36
N/A
1.95

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

3.56
9.09
10.32

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-0.08
-
6.61

PAT CAGR (%)

10 Years
5 Years
3 Years

-
2.93
18.48

P:E (Median)

8 Years
5 Years
3 Years

0.53
-
-

P:BV (Average)

8 Years
5 Years
3 Years

1.35
0.90
1.07

EV:EBITDA (Average)

8 Years
5 Years
3 Years

23.29
28.82
20.50

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 389.75 346.67 12.43% 399.24 310.06 28.76% 362.43 251.95 43.85% 333.83 265.64 25.67%
Expenses 349.55 338.36 3.31% 368.65 318.80 15.64% 343.11 294.11 16.66% 341.14 296.77 14.95%
EBITDA 40.20 8.31 383.75% 30.59 -8.73 - 19.32 -42.16 - -7.31 -31.13 -
EBIDTM 10.31% 2.40% 7.66% -2.82% 5.33% -16.73% -2.19% -11.72%
Other Income 8.77 5.83 50.43% 7.04 3.79 85.75% 9.94 15.43 -35.58% 7.58 10.78 -29.68%
Interest 1.38 2.48 -44.35% 1.76 2.93 -39.93% 2.36 1.76 34.09% 3.83 3.02 26.82%
Depreciation 26.11 27.36 -4.57% 25.22 28.32 -10.95% 25.62 28.64 -10.54% 27.26 26.46 3.02%
PBT 21.48 -15.70 - -114.97 -143.83 - 69.30 -57.12 - -30.81 -54.85 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 20.61 -100.00%
PAT 21.48 -15.70 - -114.97 -143.83 - 69.30 -57.12 - -30.81 -75.46 -
PATM 5.51% -4.53% -28.80% -46.39% 19.12% -22.67% -9.23% -28.41%
EPS 3.05 -2.23 - -16.33 -20.43 - 9.84 -8.11 - -4.38 -10.72 -

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 446.43 423.19 5.49% 431.70 402.10 7.36% 434.38 302.50 43.60% 415.63 328.82 26.40%
Expenses 402.94 395.17 1.97% 406.35 385.62 5.38% 396.26 345.26 14.77% 406.87 347.13 17.21%
EBITDA 43.50 28.02 55.25% 25.35 16.48 53.82% 38.12 -42.76 - 8.76 -18.31 -
EBIDTM 9.74% 6.62% 5.87% 4.10% 8.77% -14.14% 2.11% -5.57%
Other Income 3.86 8.63 -55.27% 6.15 5.11 20.35% 11.28 16.35 -31.01% 5.54 9.21 -39.85%
Interest 4.03 5.76 -30.03% 4.59 5.52 -16.85% 5.58 4.09 36.43% 6.73 4.69 43.50%
Depreciation 28.33 28.77 -1.53% 27.16 29.68 -8.49% 27.86 30.78 -9.49% 29.46 28.43 3.62%
PBT 15.00 2.12 607.55% -125.87 -47.16 - 83.97 -61.28 - -21.88 -47.25 -
Tax 5.74 2.79 105.73% 3.44 -2.89 - -0.02 2.65 - 2.61 23.41 -88.85%
PAT 9.25 -0.67 - -129.31 -44.27 - 83.99 -63.93 - -24.49 -70.67 -
PATM 2.07% -0.16% -29.95% -11.01% 19.34% -21.13% -5.89% -21.49%
EPS 1.31 -0.09 - -18.37 -6.29 - 11.93 -9.08 - -3.48 -10.04 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,485.25 1,442.17 1,072.43 942.93 1,123.97 904.44 975.88 1,231.38 1,418.41 1,220.52 1,090.98 Net Sales Growth 26.48% 34.48% 13.73% -16.11% 24.27% -7.32% -20.75% -13.19% 16.21% 11.87% Cost Of Goods Sold 698.64 592.47 455.40 324.56 359.33 311.23 339.36 274.57 188.07 395.62 375.39 Gross Profit 786.61 849.69 617.03 618.37 764.64 593.21 636.52 956.81 1,230.34 824.90 715.59 GP Margin 52.96% 58.92% 57.54% 65.58% 68.03% 65.59% 65.23% 77.70% 86.74% 67.59% 65.59% Total Expenditure 1,402.45 1,391.25 1,165.35 986.48 1,028.51 995.05 1,034.20 1,214.03 1,252.60 1,078.24 989.74 Power & Fuel Cost - 105.64 101.41 77.12 67.95 72.14 75.43 48.26 40.76 37.34 38.36 % Of Sales - 7.33% 9.46% 8.18% 6.05% 7.98% 7.73% 3.92% 2.87% 3.06% 3.52% Employee Cost - 283.14 270.86 250.79 234.04 205.16 176.76 146.54 117.68 209.60 178.04 % Of Sales - 19.63% 25.26% 26.60% 20.82% 22.68% 18.11% 11.90% 8.30% 17.17% 16.32% Manufacturing Exp. - 222.94 189.07 189.10 207.65 139.62 136.04 115.50 90.53 132.41 129.61 % Of Sales - 15.46% 17.63% 20.05% 18.47% 15.44% 13.94% 9.38% 6.38% 10.85% 11.88% General & Admin Exp. - 93.26 88.02 82.51 94.82 196.55 200.15 566.05 722.03 145.52 132.64 % Of Sales - 6.47% 8.21% 8.75% 8.44% 21.73% 20.51% 45.97% 50.90% 11.92% 12.16% Selling & Distn. Exp. - 93.79 56.88 53.45 61.44 66.88 87.17 52.96 65.40 132.40 127.44 % Of Sales - 6.50% 5.30% 5.67% 5.47% 7.39% 8.93% 4.30% 4.61% 10.85% 11.68% Miscellaneous Exp. - 0.00 3.70 8.95 3.28 3.48 19.29 10.15 28.13 25.35 127.44 % Of Sales - 0% 0.35% 0.95% 0.29% 0.38% 1.98% 0.82% 1.98% 2.08% 0.76% EBITDA 82.80 50.92 -92.92 -43.55 95.46 -90.61 -58.32 17.35 165.81 142.28 101.24 EBITDA Margin 5.57% 3.53% -8.66% -4.62% 8.49% -10.02% -5.98% 1.41% 11.69% 11.66% 9.28% Other Income 33.33 30.39 41.85 42.07 47.37 99.17 101.54 3,280.20 7.19 22.71 20.31 Interest 9.33 10.42 9.38 2.07 1.30 1.28 0.62 3.17 2.00 2.29 2.37 Depreciation 104.21 105.46 105.98 83.19 75.89 71.09 61.71 45.04 39.41 34.99 37.68 PBT -55.00 -34.57 -166.43 -86.75 65.65 -63.81 -19.11 3,249.34 131.60 127.70 81.50 Tax 0.00 0.00 20.61 -31.32 11.56 -7.50 -27.91 692.74 27.73 23.69 17.10 Tax Rate 0.00% 0.00% -7.38% 36.10% 17.61% 11.75% 146.05% 21.32% 21.07% 19.08% 20.98% PAT -55.00 -92.18 -299.70 -55.43 54.08 -56.32 8.80 2,556.60 103.87 100.48 64.40 PAT before Minority Interest -55.00 -92.18 -299.70 -55.43 54.08 -56.32 8.80 2,556.60 103.87 100.48 64.40 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -3.70% -6.39% -27.95% -5.88% 4.81% -6.23% 0.90% 207.62% 7.32% 8.23% 5.90% PAT Growth 0.00% - - - - - -99.66% 2,361.35% 3.37% 56.02% EPS -7.81 -13.09 -42.57 -7.87 7.68 -8.00 1.25 363.15 14.75 14.27 9.15

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,728.14 1,704.89 1,343.02 1,269.83 1,235.14 1,103.71 1,188.19 1,379.90 1,540.06 1,332.65 1,201.79 Net Sales Growth 18.64% 26.94% 5.76% 2.81% 11.91% -7.11% -13.89% -10.40% 15.56% 10.89% Cost Of Goods Sold 656.76 565.63 482.45 356.91 302.14 308.63 364.19 274.97 188.77 386.97 378.57 Gross Profit 1,071.38 1,139.27 860.57 912.92 933.00 795.08 823.99 1,104.93 1,351.28 945.67 823.23 GP Margin 62.00% 66.82% 64.08% 71.89% 75.54% 72.04% 69.35% 80.07% 87.74% 70.96% 68.50% Total Expenditure 1,612.42 1,604.65 1,388.58 1,197.04 1,144.03 1,154.53 1,269.21 1,358.21 1,357.62 1,168.77 1,100.79 Power & Fuel Cost - 107.14 102.84 78.05 68.89 73.02 76.39 49.23 41.62 38.25 39.39 % Of Sales - 6.28% 7.66% 6.15% 5.58% 6.62% 6.43% 3.57% 2.70% 2.87% 3.28% Employee Cost - 393.06 356.41 330.49 306.97 273.28 238.52 200.64 169.04 255.92 223.20 % Of Sales - 23.05% 26.54% 26.03% 24.85% 24.76% 20.07% 14.54% 10.98% 19.20% 18.57% Manufacturing Exp. - 227.80 194.60 193.21 215.73 232.08 147.23 125.30 103.70 150.54 145.03 % Of Sales - 13.36% 14.49% 15.22% 17.47% 21.03% 12.39% 9.08% 6.73% 11.30% 12.07% General & Admin Exp. - 133.02 119.02 109.60 123.98 147.90 229.37 594.53 744.66 167.66 153.29 % Of Sales - 7.80% 8.86% 8.63% 10.04% 13.40% 19.30% 43.09% 48.35% 12.58% 12.76% Selling & Distn. Exp. - 178.00 129.56 120.68 122.52 116.12 197.24 108.38 107.77 166.84 157.12 % Of Sales - 10.44% 9.65% 9.50% 9.92% 10.52% 16.60% 7.85% 7.00% 12.52% 13.07% Miscellaneous Exp. - 0.00 3.70 8.11 3.81 3.50 16.26 5.16 2.06 2.58 157.12 % Of Sales - 0% 0.28% 0.64% 0.31% 0.32% 1.37% 0.37% 0.13% 0.19% 0.35% EBITDA 115.73 100.24 -45.56 72.79 91.11 -50.82 -81.02 21.69 182.44 163.88 101.00 EBITDA Margin 6.70% 5.88% -3.39% 5.73% 7.38% -4.60% -6.82% 1.57% 11.85% 12.30% 8.40% Other Income 26.83 31.60 38.52 47.51 50.19 91.31 98.41 3,278.19 5.50 19.11 20.72 Interest 20.93 22.66 17.31 6.11 5.12 7.85 7.52 8.01 3.36 2.90 3.04 Depreciation 112.81 113.24 113.44 91.17 84.36 81.67 67.37 50.51 43.52 38.79 41.27 PBT -48.78 -4.06 -137.80 23.03 51.82 -49.02 -57.50 3,241.36 141.07 141.31 77.41 Tax 11.77 8.81 25.86 -11.09 17.15 11.97 -33.64 696.23 32.58 29.30 2.13 Tax Rate -24.13% -14.29% -14.66% -48.15% 33.10% -24.42% 58.50% 21.48% 23.09% 21.27% 2.75% PAT -60.56 -70.47 -202.23 33.06 34.67 -61.00 -23.87 2,545.13 108.49 108.48 75.28 PAT before Minority Interest -60.56 -70.47 -202.23 33.06 34.67 -61.00 -23.87 2,545.13 108.49 108.48 75.28 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -3.50% -4.13% -15.06% 2.60% 2.81% -5.53% -2.01% 184.44% 7.04% 8.14% 6.26% PAT Growth 0.00% - - -4.64% - - - 2,245.96% 0.01% 44.10% EPS -8.60 -10.01 -28.73 4.70 4.92 -8.66 -3.39 361.52 15.41 15.41 10.69

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 2,294.63 2,384.27 2,672.04 2,697.33 2,647.18 2,731.93 2,761.67 1,130.73 1,027.15 947.42 Share Capital 14.08 14.08 14.08 14.08 14.08 14.08 14.07 18.18 18.17 18.15 Total Reserves 2,277.48 2,358.14 2,647.28 2,675.50 2,628.28 2,714.02 2,747.01 1,111.11 1,007.83 928.41 Non-Current Liabilities 81.13 113.21 139.63 50.27 29.68 26.79 50.07 70.40 63.66 69.27 Secured Loans 38.22 63.65 89.01 0.00 0.00 0.00 0.33 0.44 0.46 0.22 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 35.80 41.91 39.96 30.41 23.51 14.60 10.76 25.33 12.58 8.88 Current Liabilities 487.94 388.66 310.42 371.45 348.27 271.50 295.88 301.81 282.61 205.00 Trade Payables 249.49 244.47 157.08 188.57 208.22 192.69 211.51 228.28 189.63 142.63 Other Current Liabilities 102.60 119.82 125.82 168.06 115.02 67.56 60.40 56.73 47.43 36.32 Short Term Borrowings 0.00 12.36 11.43 0.00 15.21 0.00 0.00 0.55 7.90 0.00 Short Term Provisions 135.85 12.01 16.09 14.83 9.81 11.25 23.97 16.25 37.65 26.05 Total Liabilities 2,863.70 2,886.14 3,122.09 3,119.05 3,025.13 3,030.22 3,107.62 1,502.94 1,373.42 1,221.69 Net Block 1,164.94 1,235.94 963.12 846.23 824.94 785.16 551.12 464.17 381.20 395.87 Gross Block 1,718.31 1,690.90 1,323.61 1,128.33 1,037.52 939.38 655.08 535.64 414.65 683.53 Accumulated Depreciation 553.37 454.95 360.49 282.11 212.58 154.22 103.96 71.47 33.45 287.67 Non Current Assets 1,454.22 1,589.96 1,748.12 1,813.69 1,520.42 1,177.12 895.56 815.69 744.42 676.73 Capital Work in Progress 122.36 147.82 494.18 567.73 330.84 90.25 235.53 247.26 232.65 118.66 Non Current Investment 42.73 38.98 126.22 287.52 252.77 245.36 86.97 85.16 102.52 117.61 Long Term Loans & Adv. 124.18 167.22 164.61 112.21 111.88 56.36 21.94 19.11 28.05 44.59 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,406.13 1,292.76 1,370.49 1,305.37 1,504.71 1,853.10 2,212.05 687.25 629.00 544.95 Current Investments 1.34 1.54 263.58 236.43 419.10 800.75 895.55 8.00 8.04 35.04 Inventories 500.53 480.19 460.69 386.12 315.57 274.18 207.76 253.98 200.66 186.48 Sundry Debtors 558.42 472.08 380.84 360.48 323.10 331.35 231.74 296.49 264.73 206.19 Cash & Bank 129.06 157.28 99.03 57.59 205.37 191.03 673.61 10.16 10.94 19.71 Other Current Assets 216.79 25.93 29.99 57.62 241.57 255.79 203.40 118.61 144.63 97.52 Short Term Loans & Adv. 192.86 155.75 136.35 207.13 182.77 192.16 145.51 100.40 121.55 80.97 Net Current Assets 918.20 904.10 1,060.07 933.91 1,156.45 1,581.60 1,916.17 385.44 346.38 339.96 Total Assets 2,860.35 2,882.72 3,118.61 3,119.06 3,025.13 3,030.22 3,107.61 1,502.94 1,373.42 1,221.68

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 2,362.42 2,435.30 2,618.41 2,556.83 2,531.35 2,619.91 2,680.08 1,063.62 954.33 867.52 Share Capital 14.08 14.08 14.08 14.08 14.08 14.08 14.07 18.18 18.17 18.15 Total Reserves 2,345.27 2,409.18 2,593.65 2,535.00 2,512.44 2,601.99 2,665.42 1,044.00 935.01 848.52 Non-Current Liabilities 92.27 108.03 143.88 49.16 43.72 10.10 46.46 64.49 76.02 74.21 Secured Loans 38.22 63.65 89.01 0.00 0.00 0.00 0.33 0.44 22.98 20.35 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 35.80 41.91 39.96 30.41 23.51 14.60 10.76 25.33 12.58 8.88 Current Liabilities 707.88 639.60 552.13 505.76 566.73 502.92 463.51 392.62 275.09 211.76 Trade Payables 299.37 290.69 183.19 210.08 250.22 221.41 226.23 210.73 163.95 138.23 Other Current Liabilities 115.19 128.34 135.06 176.97 122.04 68.45 63.03 68.01 60.56 45.86 Short Term Borrowings 155.26 208.08 215.69 100.63 184.03 199.67 150.29 97.62 12.93 1.63 Short Term Provisions 138.06 12.50 18.19 18.09 10.44 13.39 23.97 16.25 37.65 26.05 Total Liabilities 3,162.57 3,182.93 3,314.42 3,111.75 3,141.80 3,132.93 3,190.05 1,520.73 1,305.44 1,153.49 Net Block 1,195.97 1,256.66 990.03 880.42 866.06 806.29 574.45 487.22 402.60 415.99 Gross Block 1,793.08 1,750.29 1,379.74 1,193.56 1,098.27 975.96 689.74 561.37 439.53 724.65 Accumulated Depreciation 597.10 493.63 389.70 313.14 232.21 169.67 115.29 74.15 36.92 308.66 Non Current Assets 1,465.06 1,591.06 1,666.02 1,734.44 1,455.33 1,093.64 853.59 772.27 673.34 589.07 Capital Work in Progress 122.71 147.45 493.81 567.50 330.47 92.39 238.15 249.98 237.13 122.64 Non Current Investment 0.02 0.16 0.28 159.12 134.38 129.20 9.20 9.51 5.54 5.83 Long Term Loans & Adv. 124.91 168.07 165.59 112.89 112.90 56.37 24.05 25.57 28.05 44.61 Other Non Current Assets 21.45 18.72 16.30 14.52 11.52 9.39 7.74 0.00 0.00 0.00 Current Assets 1,694.16 1,588.47 1,644.92 1,377.32 1,686.47 2,039.29 2,336.47 748.46 632.11 564.42 Current Investments 1.34 1.54 263.58 236.43 419.10 800.75 895.55 8.00 8.04 35.04 Inventories 704.68 625.23 600.22 538.34 396.54 338.66 272.86 281.71 230.57 207.68 Sundry Debtors 610.40 588.62 495.43 250.27 390.14 436.05 276.92 315.32 220.09 191.58 Cash & Bank 154.32 185.36 114.10 82.45 233.81 200.99 681.46 16.14 20.13 26.96 Other Current Assets 223.42 31.31 34.60 62.21 246.88 262.83 209.68 127.29 153.28 103.17 Short Term Loans & Adv. 194.09 156.40 136.99 207.62 183.04 194.18 145.51 98.80 122.77 82.25 Net Current Assets 986.28 948.86 1,092.80 871.56 1,119.74 1,536.37 1,872.95 355.84 357.02 352.66 Total Assets 3,159.22 3,179.53 3,310.94 3,111.76 3,141.80 3,132.93 3,190.06 1,520.73 1,305.45 1,153.49

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -41.57 -117.33 -158.31 -32.61 -41.84 -251.30 -66.25 140.78 116.58 88.03 PBT -92.18 -279.09 -86.75 65.65 -63.81 -19.11 3,249.34 131.60 124.17 81.50 Adjustment 165.38 203.30 72.20 49.68 -6.17 -7.08 -3,214.36 72.37 56.10 36.30 Changes in Working Capital -114.62 -41.45 -147.82 -147.63 25.49 -217.91 -103.24 -35.89 -32.73 -11.59 Cash after chg. in Working capital -41.42 -117.24 -162.37 -32.30 -44.49 -244.10 -68.27 168.08 147.55 106.21 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.15 -0.09 4.06 -0.31 2.65 -7.20 2.01 -27.30 -30.97 -18.17 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 53.24 202.50 106.31 -80.39 -35.59 -322.63 1,648.30 -131.91 -86.73 -62.18 Net Fixed Assets -1.95 -20.93 -121.73 -327.70 -338.73 -139.02 -107.71 -135.60 154.89 -73.58 Net Investments -3.55 349.28 134.15 147.92 374.24 -63.59 -889.36 17.40 42.09 -32.73 Others 58.74 -125.85 93.89 99.39 -71.10 -120.02 2,645.37 -13.71 -283.71 44.13 Cash from Financing Activity -48.06 -61.76 95.80 -45.07 -21.02 -44.89 -929.51 -8.95 -38.63 -46.97 Net Cash Inflow / Outflow -36.39 23.41 43.81 -158.07 -98.45 -618.82 652.53 -0.08 -8.77 -21.12 Opening Cash & Equivalents 155.67 94.13 52.60 203.08 188.66 660.31 7.77 7.86 19.71 40.83 Closing Cash & Equivalent 125.65 155.67 94.13 52.60 203.08 188.66 660.31 7.77 10.94 19.71

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 16.69 -85.09 -259.61 32.98 19.82 -327.77 -112.34 68.19 111.91 78.10 PBT -61.67 -176.36 21.97 51.48 -48.21 -57.44 3,241.14 141.25 137.68 77.41 Adjustment 187.39 132.84 80.46 65.65 18.79 6.80 -3,207.66 53.31 39.65 35.57 Changes in Working Capital -102.65 -29.36 -354.43 -69.78 53.58 -264.94 -146.67 -98.65 -34.16 -16.49 Cash after chg. in Working capital 23.07 -72.88 -252.00 47.35 24.15 -315.57 -113.20 95.91 143.16 96.49 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -6.38 -12.21 -7.62 -14.36 -4.34 -12.20 0.86 -27.72 -31.25 -18.39 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 50.40 202.81 102.40 -73.56 -35.91 -286.01 1,648.33 -127.87 -85.33 -52.34 Net Fixed Assets -1.95 -20.93 -121.73 -327.70 -338.73 -139.02 -107.71 -135.60 154.89 -73.58 Net Investments -3.55 349.28 134.15 147.92 374.24 -63.59 -889.36 17.40 42.09 -32.73 Others 55.90 -125.54 89.98 106.22 -71.42 -83.40 2,645.40 -9.67 -282.31 53.97 Cash from Financing Activity -106.31 -81.30 191.23 -121.07 -62.30 -2.42 -881.13 59.23 -33.42 -50.95 Net Cash Inflow / Outflow -39.21 36.42 34.01 -161.65 -78.40 -616.19 654.86 -0.46 -6.84 -25.19 Opening Cash & Equivalents 183.75 109.20 77.46 231.52 197.05 666.07 11.21 11.67 26.96 52.15 Closing Cash & Equivalent 150.91 183.75 109.20 77.46 231.52 197.05 666.07 11.21 20.13 26.96

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 325.48 336.94 378.00 382.01 375.30 387.60 392.55 124.27 112.94 104.28 ROA -3.21% -9.98% -1.78% 1.76% -1.86% 0.29% 110.90% 7.22% 7.74% 5.30% ROE -3.95% -11.91% -2.07% 2.03% -2.10% 0.32% 131.43% 9.64% 10.19% 6.95% ROCE -3.38% -10.21% -3.08% 2.50% -2.32% -0.67% 167.06% 12.33% 12.75% 9.04% Fixed Asset Turnover 0.85 0.71 0.77 1.04 0.92 1.22 2.07 2.99 2.25 1.66 Receivable days 130.40 145.14 143.48 110.99 132.06 105.30 78.26 72.16 69.53 69.33 Inventory Days 124.11 160.11 163.90 113.93 119.00 90.13 68.41 58.46 57.16 61.90 Payable days 152.16 160.92 194.36 201.52 82.50 82.64 118.77 140.05 63.62 59.84 Cash Conversion Cycle 102.35 144.34 113.02 23.40 168.55 112.80 27.91 -9.43 63.06 71.39 Total Debt/Equity 0.03 0.04 0.05 0.00 0.01 0.00 0.00 0.00 0.01 0.00 Interest Cover -7.85 -28.75 -40.82 51.47 -48.78 -29.97 1027.03 66.88 55.19 35.41

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 335.11 344.18 370.38 362.05 358.85 371.69 380.95 116.88 104.93 95.48 ROA -2.22% -6.22% 1.03% 1.11% -1.94% -0.75% 108.06% 7.68% 8.82% 6.55% ROE -2.95% -8.04% 1.28% 1.37% -2.37% -0.90% 136.04% 10.77% 11.92% 8.95% ROCE -1.47% -5.60% 1.00% 2.12% -1.49% -1.77% 162.77% 13.42% 14.97% 9.29% Fixed Asset Turnover 0.96 0.86 0.99 1.08 1.06 1.43 2.21 3.08 2.32 1.71 Receivable days 128.35 147.31 107.17 94.63 136.61 109.51 78.30 63.41 55.72 58.55 Inventory Days 142.36 166.52 163.63 138.14 121.57 93.93 73.33 60.67 59.32 62.03 Payable days 190.38 179.25 201.09 278.03 76.39 73.41 94.97 104.25 52.00 52.61 Cash Conversion Cycle 80.33 134.58 69.71 -45.27 181.78 130.03 56.65 19.82 63.05 67.97 Total Debt/Equity 0.09 0.12 0.13 0.04 0.07 0.08 0.06 0.09 0.04 0.03 Interest Cover -1.72 -9.19 4.60 11.12 -5.25 -6.64 405.79 43.00 48.57 26.45

Top Investors:

hdfc small cap fund

dsp healthcare fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Unichem Laboratories gets VAI classification for Goa formulation facility
10th Sep 2024, 15:26 PM

Earlier, USFDA had conducted an inspection at Unichem Laboratories’ Goa formulation facility from July 08, 2024 to July 15, 2024
Read More
Unichem Lab - Quarterly Results
8th Aug 2024, 13:01 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback